catechin has been researched along with Liver Cirrhosis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (27.59) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 15 (51.72) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| George, J; Tsuchishima, M; Tsutsumi, M | 1 |
| Chen, J; Lei, Y; Liu, J; Liu, M | 1 |
| Erstad, DJ; Fuchs, BC; Fujii, T; Hirschfield, H; Hoshida, Y; Kim, RS; Lanuti, M; Lauwers, GY; Sojoodi, M; Tanabe, KK; Wei, L; Yamada, S | 1 |
| Gao, H; Hu, Y; Li, X; Tian, R; Wang, Y; Williams, BR; Xu, P; Yan, F; Ying, L; Zhao, Y | 1 |
| Ho, CT; Li, S; Wang, L; Yang, G; Yang, Y; Yuan, L; Zhao, H | 1 |
| Chen, J; Chen, K; Dai, W; Fan, X; Feng, J; Guo, C; Ji, J; Li, J; Li, S; Liu, T; Mao, Y; Wang, C; Wang, F; Wu, J; Wu, L; Yu, Q; Zhang, J; Zhou, Y | 1 |
| Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H | 1 |
| He, M; Li, Y; Liao, M; Lin, X; Luo, Y; Zhang, X | 1 |
| Cai, SY; He, HW; Shao, RG; Yu, DK; Zhang, CX; Zhang, H; Zhang, SH; Zhao, SS | 1 |
| Feng, X; Shen, K; Su, R; Xie, H; Zheng, S; Zhou, L | 1 |
| Du, N; Li, L; Wang, K; Wang, Z; Zhang, Z | 1 |
| Cao, W; Li, M; Li, Y; Liao, M; Zhang, X | 1 |
| Al-Gayyar, MM; Arffa, ML; Chang, V; Ding, X; Elsherbiny, NM; Gupta, GN; Kothari, AN; Kuo, PC; Mi, Z; Syn, W; Zapf, MA | 1 |
| Adachi, S; Hara, Y; Iwasa, J; Kubota, M; Moriwaki, H; Osawa, Y; Sakai, H; Shimizu, M; Tsurumi, H; Yasuda, Y | 1 |
| Asagiri, K; Asakawa, T; Kage, M; Kobayashi, H; Tanaka, Y; Tanikawa, K; Yagi, M | 1 |
| Fung, ML; Lau, TY; Leung, TM; Liong, EC; Nanji, AA; Tipoe, GL | 1 |
| Abraldes, JG; Berzigotti, A; Bosch, J; D'Amico, M; De Gottardi, A; García-Pagán, JC; Seijo, S; Thormann, W | 1 |
| He, M; Huang, Q; Huang, R; Liao, M; Lin, X; Wei, L; Zhang, S; Zheng, L; Zhuo, L | 1 |
| Daskalakis, C; Halegoua-De Marzio, D; Hawke, RL; Kraft, WK; Navarro, VJ; Ying, X | 1 |
| Enjoji, M; Fukushima, M; Higashi, N; Kobayashi, N; Kohjima, M; Kotoh, K; Nakamuta, M; Ohta, S | 1 |
| Cao, LQ; Chen, XL; Huang, XH; Li, W; Liu, YJ; Sun, K; Wang, Q; Zhang, LJ; Zhen, MC | 1 |
| Göbel, J; Pausch, V | 1 |
| Beck, P; Boda, Z; Dalmi, L; Misz, M; Pfliegler, G; Weisz, G | 1 |
| Ikeda, Y; Ito, K; Nose, T; Sato, I; Tajima, S; Takebe, H | 1 |
| Divald, A; Jeney, A; Lapis, K; Schaff, Z; Vajta, G; Zalatnai, A | 1 |
| Cornides, A; Deák, G; Fehér, J; Gergely, P; Láng, I; Nékám, K | 1 |
| Ausheva, LKh; Bendikov, EA; Blok, IuE; Dzhalalov, KD; Loginov, AS | 1 |
| Kostova, N; Krŭstev, Z; Lukanov, L; Maleev, A; Tsvetkova, V | 1 |
| Dement'eva, ES; Krylova, NI; Neverov, IV; Tamarkina, AD; Turitsyna, IG | 1 |
2 trial(s) available for catechin and Liver Cirrhosis
| Article | Year |
|---|---|
Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial.
Topics: Adult; Aged; Antioxidants; Cacao; Catechin; Double-Blind Method; Female; Flavonoids; Food, Formulated; Humans; Hyperemia; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Pigmentation; Postprandial Period | 2012 |
Limited sampling estimates of epigallocatechin gallate exposures in cirrhotic and noncirrhotic patients with hepatitis C after single oral doses of green tea extract.
Topics: Administration, Oral; Aged; Antioxidants; Area Under Curve; Catechin; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Plant Extracts; Tea; Time Factors | 2012 |
27 other study(ies) available for catechin and Liver Cirrhosis
| Article | Year |
|---|---|
Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis.
Topics: Animals; Body Weight; Catechin; Collagen Type I; Collagen Type IV; Dimethylnitrosamine; Fibrosis; Hepatic Stellate Cells; Hyaluronic Acid; Liver; Liver Cirrhosis; Malondialdehyde; Osteopontin; Rats | 2022 |
Potential ameliorative effects of epigallocatechin-3-gallate against cigarette smoke exposure induced renal and hepatic deficits.
Topics: Animals; Catechin; Epithelial-Mesenchymal Transition; Fibrosis; Inflammation; Kidney; Liver; Liver Cirrhosis; Male; Oxidative Stress; Rats; Tobacco Smoke Pollution; Transforming Growth Factor beta1 | 2020 |
Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.
Topics: Animals; Anticarcinogenic Agents; Biomarkers; Carcinoma, Hepatocellular; Catechin; Cellular Senescence; Diethylnitrosamine; Hepatic Stellate Cells; Liver Cirrhosis; Liver Neoplasms, Experimental; Male; Phenotype; Precancerous Conditions; Rats; Tea; Transcriptome | 2020 |
(-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis-related genes in non-alcoholic fatty liver disease.
Topics: Animals; Atorvastatin; Catechin; Disease Models, Animal; Down-Regulation; Fibrillar Collagens; Gene Expression; Humans; Liver Cirrhosis; Male; Mice, Inbred C57BL; Multigene Family; Non-alcoholic Fatty Liver Disease | 2017 |
Green Tea Catechins Effectively Altered Hepatic Fibrogenesis in Rats by Inhibiting ERK and Smad1/2 Phosphorylation.
Topics: Animals; Camellia sinensis; Catechin; Female; Humans; Liver; Liver Cirrhosis; MAP Kinase Signaling System; Phosphorylation; Plant Extracts; Rats; Rats, Sprague-Dawley; Smad1 Protein; Smad2 Protein; Transforming Growth Factor beta | 2019 |
Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis.
Topics: Animals; Biflavonoids; Carbon Tetrachloride; Catechin; Cell Line; Cell Proliferation; Down-Regulation; Hedgehog Proteins; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Morphogenesis; Neovascularization, Pathologic; Proanthocyanidins; Signal Transduction; Transforming Growth Factor beta1; Veratrum Alkaloids | 2019 |
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2014 |
Combined taurine, epigallocatechin gallate and genistein therapy reduces HSC-T6 cell proliferation and modulates the expression of fibrogenic factors.
Topics: Animals; Catechin; Cell Line; Cell Proliferation; Collagen Type I; Down-Regulation; Drug Therapy, Combination; Genistein; Liver Cirrhosis; Matrix Metalloproteinase 2; Rats; RNA, Messenger; Taurine; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta1; Up-Regulation | 2013 |
The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Topics: Animals; Bile Ducts; Catechin; Cell Line; Cholestasis; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins | 2015 |
Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation.
Topics: Animals; Bile Ducts, Intrahepatic; Catechin; Cell Death; Cholestasis; Cytokines; Disease Models, Animal; Gene Expression Regulation; Hepatic Stellate Cells; Hepatocytes; Inflammation; Liver Cirrhosis; Mice; Mitochondria; NF-kappa B; Oxidative Stress | 2015 |
Hepatoprotective Effects of Grape Seed Procyanidin B2 in Rats With Carbon Tetrachloride-induced Hepatic Fibrosis.
Topics: Animals; Antioxidants; Biflavonoids; Carbon Tetrachloride; Catechin; Cytokines; Grape Seed Extract; Liver; Liver Cirrhosis; Male; Oxidative Stress; Proanthocyanidins; Rats; Rats, Sprague-Dawley; Seeds; Vitis | 2015 |
Txn1, Ctsd and Cdk4 are key proteins of combination therapy with taurine, epigallocatechin gallate and genistein against liver fibrosis in rats.
Topics: Animals; Anticarcinogenic Agents; Carbon Tetrachloride Poisoning; Catechin; Cathepsin D; Cyclin-Dependent Kinase 4; Drug Therapy, Combination; Genistein; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Taurine; Thioredoxins; Transcriptome | 2017 |
Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.
Topics: Animals; Antioxidants; Catechin; Cell Line; Hep G2 Cells; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Male; MicroRNAs; Osteopontin; Rats, Sprague-Dawley; Tea; Up-Regulation | 2016 |
(-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.
Topics: Actins; Alanine Transaminase; Animals; Anticarcinogenic Agents; Aspartate Aminotransferases; Carbon Tetrachloride; Catechin; Gene Expression; Liver; Liver Cirrhosis; Male; Rats; Rats, Wistar; Receptor, IGF Type 1; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger | 2009 |
The antioxidant effect of green tea catechin ameliorates experimental liver injury.
Topics: Actins; Alanine Transaminase; Aldehydes; Animals; Antioxidants; Aspartate Aminotransferases; Camellia sinensis; Catechin; Cholestasis; Deoxyguanosine; Disease Models, Animal; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Male; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor AP-1; Transforming Growth Factor beta1 | 2010 |
Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice.
Topics: Actins; Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Catechin; Chemical and Drug Induced Liver Injury; Collagen Type I; Cyclooxygenase 2 Inhibitors; Liver Cirrhosis; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Oxidative Stress; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Tyrosine | 2010 |
Combination therapy with taurine, epigallocatechin gallate and genistein for protection against hepatic fibrosis induced by alcohol in rats.
Topics: Actins; Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Catechin; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Ethanol; gamma-Glutamyltransferase; Genistein; Liver Cirrhosis; Peroxidase; Proto-Oncogene Proteins c-bcl-2; Rats; RNA, Messenger; Smad3 Protein; Taurine | 2012 |
Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells.
Topics: Actins; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Cell Line; Flavonoids; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Hepatocytes; Humans; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Liver Cirrhosis; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphorylation; Polyphenols; Protein-Tyrosine Kinases; rho GTP-Binding Proteins; Stress Fibers; Tea | 2005 |
Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis.
Topics: Animals; Beverages; Carbon Tetrachloride Poisoning; Catechin; Cell Culture Techniques; Disease Models, Animal; Disease Progression; Enzyme Activation; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinase 2; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2007 |
[Immunohematologic studies on the correlations between (+)-cyanidanol-3-(catergen) therapy and hemolytic anemia].
Topics: Anemia, Hemolytic, Autoimmune; Benzopyrans; Catechin; Erythrocytes; Hemagglutination Tests; Hepatitis C; Humans; Liver Cirrhosis; Penicillin G | 1983 |
Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
Topics: Adult; Aged; Blood Coagulation Tests; Catechin; Clinical Enzyme Tests; Fatty Liver; Female; Hemostasis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Time Factors | 1984 |
[Effects of cianidanol (KB-53) on liver cirrhosis induced by CCl4 in rats: a pathological investigation].
Topics: Animals; Benzopyrans; Carbon Tetrachloride Poisoning; Catechin; Flavonoids; Liver; Liver Cirrhosis; Male; Rats; Rats, Inbred Strains | 1983 |
Experimental studies on the effect of hepatoprotective compounds.
Topics: Aminoimidazole Carboxamide; Animals; Carbon Tetrachloride Poisoning; Catechin; Chemical and Drug Induced Liver Injury; Epoprostenol; Flavonoids; Galactosamine; Imidazoles; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred F344; Ribonucleosides; Silymarin | 1986 |
Free radicals in tissue damage in liver diseases and therapeutic approach.
Topics: Aminoimidazole Carboxamide; Antioxidants; Catechin; Flavonoids; Free Radicals; Humans; Imidazoles; Immunosuppressive Agents; Liver; Liver Cirrhosis; Lymphocyte Activation; Quinolines; Ribonucleosides; Silymarin; Superoxide Dismutase; Thiazoles | 1986 |
[Treatment of chronic diseases of the liver with catergen].
Topics: Adolescent; Adult; Aged; Benzopyrans; Catechin; Chronic Disease; Fatty Liver, Alcoholic; Female; Hepatitis, Chronic; Humans; Lipid Peroxides; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Phosphatidylcholines | 1986 |
[Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
Topics: Adult; Aged; Benzopyrans; Catechin; Chronic Disease; Fatty Liver; Female; Hepatitis; Hepatitis, Chronic; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1985 |
[Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
Topics: Adult; Aged; Antioxidants; Benzopyrans; Catechin; Chronic Disease; Hepatitis; Humans; Liver; Liver Cirrhosis; Middle Aged | 1985 |